Socially Responsible Investing
To Bayer, sustainability means safeguarding our future viability and, as part of corporate strategy, is integrated into everyday procedures. We want to safeguard our company’s long-term success in balance with ecological responsibility and societal acceptance.
We attach great importance to dialogue with our stakeholders. We continue our dialogue about our sustainability commitment with market participants whose investment decisions are aligned to ecological, social and governance criteria - through targeted one-on-one meetings, conference calls and roadshows. The Sustainability & Business Stewardship department, in coordination with the Investor Relations department, is in charge of informing socially responsible investors and rating agencies.
We inform our stakeholders on non-financial information and performance indicators in our integrated Annual Report.
Please find below the links to more information on selective sustainability focus topics - for example on the demands made on good corporate governance, our measures of product safety, or our access to healthcare initiatives, etc.
|Compliance at BayerCorporate GovernanceRisk Management|
Access to Medicine
|Clinical Studies Bee Care InitiativesSmallholder FarmersClimate Change Responsible Marketing|
For Bayer, sustainability means shaping the future successfully and, as part of our corporate strategy, is an integral part of our day-to-day work routines.
We underline our mission as a company that acts sustainably through our commitment to the U.N. Global Compact and the Responsible Care™ initiative, and through our active global involvement in leading initiatives such as the World Business Council for Sustainable Development (WBCSD). Bayer is committed to the U.N. Sustainable Development Goals (SDGs) and released a position outlining the company’s stance on these in 2016. Our innovations, products and services make a contribution to overcoming some of the biggest global challenges, including the SDGs of zero hunger and good global health care in particular.
To advance the consistent implementation of our strategy, we have set ambitious group targets for our company in the areas of growth and profitability, innovation, sustainability and employees.
As part of Bayer’s corporate strategy, sustainability is firmly established at Board level. Responsibility for the Group’s sustainable orientation lies with the Board of Management member responsible for Human Resources, Technology and Sustainability in his role as Chief Sustainability Officer, and with the Corporate Health, Safety & Sustainability function introduced in 2016. Operational implementation is effected with the help of nonfinancial targets and performance indicators throughout the value chain. It is based on a clear definition of responsibilities in the corporate structure and the identification of key areas of activity using a materiality analysis. Corporate policies ensure our sustainability principles are firmly established in business operations and are implemented through management systems, committees and processes. The ongoing review and revision of directives and regular internal audits ensure that our management systems are continuously improved and aligned to the specific respective requirements.
With the Annual Report 2013 we combined our financial and our sustainability reporting for the first time. Our aim in integrating the two previous publications is to elucidate the interactions between financial, ecological and societal factors and underline their influence on our company’s long-term development.
The Bayer Group’s sustainability reporting complies with the “comprehensive” option of the G4 Guidelines of the Global Reporting Initiative (GRI) and is aligned to the ten principles of the U.N. Global Compact (UNGC). The detailed GRI content index with the corresponding UNGC principles can be found in the “Further Information” section in the augmented version of the Annual Report. Online we also publish a separate PDF file with a summary of the U.N. Global Compact Progress Report based on the criteria of the Blueprint for Corporate Sustainability Leadership.
You can find more detailed information about the integration of sustainability into our business practices as well as financial and non-financial key figures for previous years in our former integrated annual reports and former sustainable development reports.
In 2016, Bayer again qualified for inclusion in major sustainability indices, including the Dow Jones Sustainability World, the FTSE4Good (Europe, Global and Environmental Leaders Europe 40) and the STOXX® Global ESG Leaders. In addition, Bayer was once again evaluated by the CDP as one of the leading international pharmaceutical companies in the areas of climate protection and sustainable water management.
|Dow Jones Sustainability World||World|
|FTSE4Good Environmental Leaders Europe 40||Europe|
|MSCI ACWI Low Carbon Target Index||World|
|STOXX® Europe Sustainability||Europe|
|STOXX® Global ESG Impact||World|